高榕创投
@gaorong
创造美好生活
499 articles
Articles
Gaorong Ventures wishes you a Happy New Year 2026!
A new year begins — may it bring brighter days ahead.
AncorBio in the Hot ADC Race: Mining Differentiated Value in the Innovative Drug 2.0 Era | Gaorong Future
China will inevitably give rise to its own global MNCs.
Securing 100+ Manufacturing Clients: Sequx's Next-Gen Multi-Agent Platform Boosts Both Efficiency and Quality in Industrial Design | Gaorong Future
Use AI to empower the entire process, from industrial design through manufacturing.
Warm congratulations to Seyond on its successful Hong Kong IPO. Gaorong Ventures led the company's angel round.
Leading the high-performance LiDAR segment.
Chinese online marketplace operator "Quantgroup" successfully listed on the Hong Kong Stock Exchange, with Gaorong Ventures as a co-lead investor in its Series A round.
Facilitating precise matching between consumer demand and industrial supply.
ARR Keeps Climbing: From Deel to Dianxiaomi, Here's a Guide to AI-Powered Global Growth | Ronghui
Closed-Door Session on Global Growth
Andon Therapeutics Raises Over 400 Million Yuan in Series C Funding to Accelerate Phase III Clinical Trials for Revolutionary Pan-Anemia Drug
Focused on R&D of novel drugs for kidney diseases, pan-anemia conditions, and cancer.
Surgical Robot Maker Cornerstone Robotics Raises ~$200M in Oversubscribed Round to Accelerate Global Expansion
"The foundation of quality healthcare."
Moonshot AI Releases Kimi K2 Thinking, Its Strongest Open-Source Reasoning Model to Date
Models are thinking agents.
Westlake Valley Intelligent Pharma: Cracking the AAV Delivery Challenge with AI, Entering the Super Track of In Vivo CAR-T — Gene Therapy's Moment in China | Gaorong Future
Chinese gene therapies have a real shot at genuine innovation — even leapfrogging the competition.